Bilateral optic neuritis in acute hepatitis C

Journal of Neuro-Ophthalmology

Volumn 29, Issue 2, 2009, Pages 128-133

  Siddiqui, Junaid ^a   Rouleau, Jacinthe ^a   Lee, Andrew G ^a   Sato, Yutaka ^a   Voigt, Michael D ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67651233006     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e3181989783     Document Type: Article

References (41)

1. Jouhadi Z, Ouazzani I, Abid A, et al. Devic’s optic neuromyelitis and viral hepatitis type A: a paediatric case report (in French). Rev Neurol (Paris) 2004; 160: 1198-202.
2. McKibbin M, Cleland PG, Morgan SJ. Bilateral optic neuritis after hepatitis A. J Neurol Neurosurg Psychiatry 1995;58: 508.
3. Achiron LR. Postinfectious hepatitis B optic neuritis. Optom Vis Sci 1994; 71: 53-6.
4. Farthing CF, Howard RS, Thin RN. Papillitis and hepatitis. Br Med J (Clin Res Ed) 1986;292;1712.
5. Galli M, Morelli R, Casellato A, et al. Retrobulbar optic neuritis in a patient with acute type B hepatitis. J Neurol Sci 1986; 72: 195-200.
6. Patel K, Muir AJ, McHutchison JG. Diagnosis and treatment of chronic hepatitis C infection. BMJ 2006; 332: 1013-7.
7. Cox AL, Netski DM, Mosbruger T, et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis 2005; 40: 951-8.
8. Wang CC, Krantz E, Klarquist J, et al. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 2007; 196: 1474-82.
9. Albitar S, Bourgeon B, Genin R, et al. Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrol Dial Transplant 1997; 12: 2169-70.
10. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
11. Heckmann JG, Kayser C, Heuss D, et al. Neurological manifestations of chronic hepatitis C. J Neurol 1999; 246: 486-91.
12. Kayali Z, Buckwold VE, Zimmerman B, et al. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 2002; 36: 978-85.
13. Arena MG, Ferlazzo E, Bonanno D, et al. Cerebral vasculitis in a patient with HCV-related type II mixed cryoglobulinemia. J Investig Allergol Clin Immunol 2003; 13: 135-6.
14. Cappellari A, Origgi L, Spina MF, et al. Central nervous system involvement in HCV-related mixed cryoglobulinemia. Electromyogr Clin Neurophysiol 2006; 46: 149-58.
15. Casato M, Saadoun D, Marchetti A, et al. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J Rheumatol 2005; 32: 484-8.
16. Dawson TM, Starkebaum G. Isolated central nervous system vasculitis associated with hepatitis C infection. J Rheumatol 1999; 26: 2273-6.
17. Fragoso M, Carneado J, Tuduri I, et al. Essential mixed cryoglobulinemia as a cause of ischemic cerebrovascular accident (in Spanish). Rev Neurol 2000;30(5): 444-6.
18. Origgi L, Vanoli M, Carbone A, et al. Central nervous system involvement in patients with HCV-related cryoglobulinemia. Am J Med Sci 1998; 315: 208-10.
19. Propst T, Propst A, Nachbauer K, et al. Papillitis and vasculitis of the arteria spinalis anterior as complications of hepatitis C reinfection after liver transplantation. Transpl Int 1997; 10: 234-7.
20. Buccoliero R, Gambelli S, Sicurelli F, et al. Leukoencephalopathy as a rare complication of hepatitis C infection. Neurol Sci 2006; 27: 360-3.
21. Laskus T, Radkowski M, Adair DM, et al. Emerging evidence of hepatitis C virus neuroinvasion. AIDS 2005;19: S140-4.
22. Morsica G, Bernardi MT, Novati R, et al. Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients. J Med Virol 1997; 53: 252-4.
23. Radkowski M, Wilkinson J, Nowicki M, et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 2002; 76: 600-8.
24. Forton DM, Karayiannis P, Mahmud N, et al. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004; 78: 5170-83.
25. Weiner HL, Hauser SL. Neuroimmunology. II: Antigenic specificity of the nervous system. Ann Neurol 1982; 12: 499-50.
26. Muller BR. Analysis of serum angiotensin-converting enzyme. Ann Clin Biochem 2002; 39: 436-43.
27. Willson RA. Visual side effects of pegylated interferon during therapy for chronic hepatitis C infection. J Clin Gastroenterol 2004; 38: 717-22.
28. Gupta R, Singh S, Tang R, et al. Anterior ischemic optic neuropathy caused by interferon alpha therapy. Am J Med 2002; 112: 683-4.
29. Nicolo M, Artioli S, La Mattina GC, et al. Branch retinal artery occlusion combined with branch retinal vein occlusion in a patient with hepatitis C treated with interferon and ribavirin. Eur J Ophthalmol 2005; 15: 811-4.
30. Akyuz F, Akyuz U, Kocaman O, et al. Rare complication of interferon therapy: retinal vein thrombosis. Acta Gastroenterol Belg 2005; 68: 394-5.
31. Kiratli H, Irkec M. Presumed interferon-associated bilateral macular arterial branch obstruction. Eye 2000; 14: 920-2.
32. Nadir A, Amin A, Chalisa N, et al. Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature. J Viral Hepat 2000; 7: 466-70.
33. Ogata H, Suzuki H, Shimizu K, et al. Pegylated interferon-associated retinopathy in chronic hepatitis C patients. Jpn J Ophthalmol 2006; 50: 293-5.
34. Tu KL, Bowyer J, Schofield K, et al. Severe interferon associated retinopathy. Br J Ophthalmol 2003; 87: 247-8.
35. Neubauer AS, Hoops JP. Interferon-induced retinopathy in asymptomatic cancer patients. Ophthalmology 2002; 109: 821-2.
36. Jain K, Lam WC, Waheeb S, et al. Retinopathy in chronic hepatitis C patients during interferon treatment with ribavirin. Br J Ophthalmol 2001; 85: 1171-3.
37. Suzuki T, Yonemura K, Miyaji T, et al. Progressive renal failure and blindness due to retinal hemorrhage after interferon therapy for hepatitis C virus-associated membranoproliferative glomerulonephritis. Intern Med 2001; 40: 708-12.
38. Hayasaka S, Fujii M, Yamamoto Y, et al. Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa. Br J Ophthalmol 1995; 79: 150-2.
39. Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350-6.
40. Okuse C, Yotsuyanagi H, Nagase Y, et al. Risk factors for retinopathy associated with interferon alpha-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2006; 12: 3756-9.
41. Willson RL, Ross RD, Willson LM, et al. Interferon-associated retinopathy in a young, insulin-dependent diabetic patient. Retina 2000; 20: 413-5.